Does prostate cancer family history have an impact on active surveillance adherence in men with low- or favourable intermediate risk disease?

被引：0
|
作者：
Leni, R. [1 ]
Stabile, A. [1 ]
Gandaglia, G. [1 ]
Mazzone, E. [1 ]
Cucchiara, V [1 ]
Bandini, M. [1 ]
Pellegrino, A. [1 ]
De Angelis, M. [1 ]
Quarta, L. [1 ]
Zaurito, P. [1 ]
Robesti, D. [1 ]
Fossati, N. [2 ]
Brembilla, G. [3 ]
Zaffuto, E. [4 ]
Deho, F. [4 ]
De Cobelli, F. [3 ]
Montorsi, F. [1 ]
Briganti, A. [1 ]
机构：
[1] Univ Vita Salute San Raffaele, Dept Urol, IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Svizzera Italiana, Dept Urol, Ente Osped Cantonale, Lugano, Switzerland
[3] Univ Vita Salute San Raffaele, Dept Radiol, IRCCS Osped San Raffaele, Milan, Italy
[4] Osped Circolo & Macchi Fdn, Dept Urol, Varese, Italy
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0953
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Active surveillance and focal therapy for low-intermediate risk prostate cancer
    Klotz, Laurence
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 342 - 354
  • [42] Active surveillance for intermediate-risk prostate cancer
    Madhur Nayan
    Filipe L. F. Carvalho
    Adam S. Feldman
    World Journal of Urology, 2022, 40 : 79 - 86
  • [43] Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate-Risk Prostate Cancer in the US Between 2010 and 2018
    Al Awamlh, Bashir Al Hussein
    Barocas, Daniel A. A.
    Zhu, Alec
    Tosoian, Jeffrey J. J.
    Ponsky, Lee
    Negoita, Serban
    Shoag, Jonathan E. E.
    JAMA INTERNAL MEDICINE, 2023, 183 (06) : 608 - 611
  • [44] Active surveillance in intermediate risk prostate cancer: is it safe?
    Krishnananthan, Nishanth
    Lawrentschuk, Nathan
    INTERNATIONAL BRAZ J UROL, 2016, 42 (03): : 418 - 421
  • [45] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [46] Active surveillance for intermediate-risk prostate cancer
    Dall'Era, M. A.
    Klotz, L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 1 - 6
  • [47] Active surveillance for intermediate-risk prostate cancer
    Nayan, Madhur
    Carvalho, Filipe L. F.
    Feldman, Adam S.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 79 - 86
  • [48] Active surveillance for intermediate-risk prostate cancer
    M A Dall'Era
    L Klotz
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 1 - 6
  • [49] Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance EDITORIAL COMMENT
    Morash, Chris
    JOURNAL OF UROLOGY, 2017, 198 (03): : 598 - 599
  • [50] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345